1. Home
  2. ARAY vs ASRT Comparison

ARAY vs ASRT Comparison

Compare ARAY & ASRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.39

Market Cap

68.6M

Sector

Health Care

ML Signal

HOLD

Logo Assertio Holdings Inc.

ASRT

Assertio Holdings Inc.

BUY

Current Price

$13.56

Market Cap

76.0M

Sector

Health Care

ML Signal

BUY

Company Overview

Basic Information
Metric
ARAY
ASRT
Founded
1990
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.6M
76.0M
IPO Year
2006
2004

Fundamental Metrics

Financial Performance
Metric
ARAY
ASRT
Price
$0.39
$13.56
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
1
Target Price
$3.50
$35.00
AVG Volume (30 Days)
1.4M
42.2K
Earning Date
04-29-2026
03-16-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
N/A
EPS
N/A
N/A
Revenue
N/A
$118,713,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$4.58
$16.87
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.33
$0.51
52 Week High
$2.10
$13.90

Technical Indicators

Market Signals
Indicator
ARAY
ASRT
Relative Strength Index (RSI) 31.64 70.68
Support Level $0.33 $0.69
Resistance Level $0.63 N/A
Average True Range (ATR) 0.04 0.65
MACD 0.00 0.15
Stochastic Oscillator 27.25 86.84

Price Performance

Historical Comparison
ARAY
ASRT

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About ASRT Assertio Holdings Inc.

Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older and Zipsor, liquid-filled capsules for relief of mild to moderate pain.

Share on Social Networks: